HealthStream Q3 10-Q: Revenue Up 8.9% to $83.3M, EPS Down to $0.18, Two New Data-Breach Suits
HSTM sits 52% above its 52-week low of $19.5 on elevated volume (1.9× avg).
Summary
HealthStream's Q3 10-Q confirms 8.9% revenue growth to $83.3 million with lower operating income and $0.18 EPS, and discloses two new class actions tied to its July 2026 data breach plus a $50 million revolver extended to 2031.
Key Events · Earnings and Guidance · HSTM
-
Q3 Revenue Grows, Profit Falls
Revenue rose 8.9% to $83.3 million from $76.5 million, but operating income fell 13.0% to $6.6 million and diluted EPS dropped to $0.18 from $0.20.
-
Two New Data-Breach Class Actions
Putative class actions Venson (filed September 24, 2026) and Iraklianos (filed September 26, 2026) were brought over the July 29, 2026 cybersecurity incident; no damages amount is specified and no class certified.
-
Wage-and-Hour Collective Action Pending
Riley v. HealthStream, filed May 27, 2026, alleges Solution Executive sales employees were misclassified as exempt and denied overtime under the FLSA; discovery is ongoing and loss cannot be estimated.
-
Balance Sheet Strengthened by Placement
Cash of $59.0 million plus $56.2 million of marketable securities at September 30, 2026, after the September private placement of 1,355,932 shares at $29.50 for about $40.0 million.
Analysis · HSTM · Technology
The 10-Q confirms the Q3 numbers already released November 2 — revenue of $83.3 million, up 8.9%, but operating income down 13.0% to $6.6 million and diluted EPS down to $0.18 from $0.20 — and adds the detail the 8-K did not carry. The most consequential new item is litigation: two putative class actions (Venson, filed September 24, 2026, and Iraklianos, filed September 26, 2026) over the July 29, 2026 cybersecurity breach, on top of a May 2026 FLSA collective action over overtime pay for Solution Executive sales staff. Neither has an estimable loss range yet, so the financial exposure is unquantified rather than contained. Against that, the balance sheet is strong: $59.0 million of cash plus $56.2 million of marketable securities, $58.0 million of nine-month operating cash flow, no borrowings on the $50 million revolver that was extended to September 2031, and roughly $686 million of remaining performance obligations. The September private placement of 1.36 million shares at $29.50 raised about $40 million and lifted shares outstanding to 30.6 million.
How filings like this one have moved
In the 30 days to Nov 17, 2026, 38% of the 3791 measured filings Wiseek scored 7 moved their stock by 5% or more by the next session's close. The median move was 0.00%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, HSTM was trading at $29.60 on NASDAQ in the Technology sector, with a market capitalization of approximately $905.6M. The 52-week trading range was $19.50 to $35.61. This filing was assessed with negative market sentiment and an importance score of 7 out of 10.